Healthcare provider profile · identity verified

Christopher Erick Rivera, M.D.

Family Practice · EVANSVILLE, IN · NPI 1326200080

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	609	144
Lisinopril	Lisinopril	549	136
Levothyroxine Sodium	Levothyroxine Sodium	517	95
Omeprazole	Omeprazole	414	98
Metoprolol Succinate	Metoprolol Succinate	331	77
Metformin Hcl	Metformin Hcl	322	81
Losartan Potassium	Losartan Potassium	320	84
Amlodipine Besylate	Amlodipine Besylate	316	85
Furosemide	Furosemide	313	60
Gabapentin	Gabapentin	294	65
Pravastatin Sodium	Pravastatin Sodium	261	68
Fluoxetine Hcl	Fluoxetine Hcl	259	47
Trazodone Hcl	Trazodone Hcl	246	51
Allopurinol	Allopurinol	230	59
Glipizide Er	Glipizide	220	46
Pantoprazole Sodium	Pantoprazole Sodium	202	53
Sertraline Hcl	Sertraline Hcl	198	37
Chlorthalidone	Chlorthalidone	191	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	182	54
Warfarin Sodium	Warfarin Sodium	181	22
Oxybutynin Chloride Er	Oxybutynin Chloride	180	36
Hydrochlorothiazide	Hydrochlorothiazide	178	51
Eliquis	Apixaban	169	30
Metoprolol Tartrate	Metoprolol Tartrate	163	42
Tramadol Hcl	Tramadol Hcl	161	51
Carvedilol	Carvedilol	153	36
Rosuvastatin Calcium	Rosuvastatin Calcium	152	36
Albuterol Sulfate Hfa	Albuterol Sulfate	151	50
Tamsulosin Hcl	Tamsulosin Hcl	148	41
Lorazepam	Lorazepam	139	38
Simvastatin	Simvastatin	139	36
Paroxetine Hcl	Paroxetine Hcl	133	22
Potassium Chloride	Potassium Chloride	133	35
Buspirone Hcl	Buspirone Hcl	132	28
Fluticasone Propionate	Fluticasone Propionate	120	43
Clopidogrel	Clopidogrel Bisulfate	112	24
Duloxetine Hcl	Duloxetine Hcl	109	20
Metformin Hcl Er	Metformin Hcl	103	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	99	29
Alprazolam	Alprazolam	92	24
Montelukast Sodium	Montelukast Sodium	90	22
Lovastatin	Lovastatin	81	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	79	11
Trulicity	Dulaglutide	78	12
Citalopram Hbr	Citalopram Hydrobromide	77	17
Venlafaxine Hcl Er	Venlafaxine Hcl	77	18
Spironolactone	Spironolactone	76	16
Alendronate Sodium	Alendronate Sodium	72	17
Prednisone	Prednisone	66	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	13
Ozempic	Semaglutide	63	14
Jardiance	Empagliflozin	60	12
Pregabalin	Pregabalin	60	15
Ezetimibe	Ezetimibe	58	17
Memantine Hcl	Memantine Hcl	57	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	56	12
Famotidine	Famotidine	51	15
Bupropion Xl	Bupropion Hcl	50	suppressed
Meloxicam	Meloxicam	50	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	suppressed
Donepezil Hcl	Donepezil Hcl	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	37
Primidone	Primidone	44	suppressed
Topiramate	Topiramate	43	suppressed
Etodolac	Etodolac	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Atenolol	Atenolol	40	suppressed
Ondansetron Odt	Ondansetron	40	14
Januvia	Sitagliptin Phosphate	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Mirtazapine	Mirtazapine	37	suppressed
Brilinta	Ticagrelor	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	19
Fenofibrate	Fenofibrate	33	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Glipizide	Glipizide	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Nabumetone	Nabumetone	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Diazepam	Diazepam	23	suppressed
Nystatin	Nystatin	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fluconazole	Fluconazole	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Estradiol	Estradiol	19	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Risperidone	Risperidone	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Azithromycin	Azithromycin	17	16
Verapamil Sr	Verapamil Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Finasteride	Finasteride	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nystop	Nystatin	13	suppressed
Ramipril	Ramipril	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Cimetidine	Cimetidine	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Valsartan	Valsartan	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Digoxin	Digoxin	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error